Revefenacin

CAS: 864750-70-9

Ref. 3D-FR178690

Produktinformation

• Name: Revefenacin
• Synonyme: Carbamic acid, N-[1,1′-biphenyl]-2-yl-, 1-[2-[[4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl ester, TD 4208, 1-[2-[[4-[[4-(Aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl N-[1,1′-biphenyl]-2-ylcarbamate, Carbamic acid, [1,1′-biphenyl]-2-yl-, 1-[2-[[4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl ester

Beschreibung

Revefenacin is a long-acting anticholinergic agent that is used to treat chronic bronchitis. It is administered via the mouth and lungs. Revefenacin has shown efficacy in treating chronic bronchitis, with a reduction in the number of exacerbations and improvement in lung function. Revefenacin was approved by the United States Food and Drug Administration (USFDA) as a long-acting anticholinergic drug for the treatment of chronic bronchitis. The most common adverse effects are dry mouth, blurred vision, constipation, diarrhea, dizziness, fatigue, headache, impotence, insomnia, nausea, urinary retention. !--END-->/li>

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 597.75 g/mol
• Formel: C₃₅H₄₃N₅O₄
• Reinheit: Min. 95%